Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 8 -0.50 (-5.88%)
As of 03:48 AM Eastern

ABDX vs. YGEN, GDR, VRCI, AGL, and PRM

Should you buy Abingdon Health stock or one of its competitors? Abingdon Health's main competitors and comparable companies include Yourgene Health (YGEN), genedrive (GDR), Verici Dx (VRCI), ANGLE (AGL), and Proteome Sciences (PRM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Abingdon Health compare to Yourgene Health?

Abingdon Health (LON:ABDX) and Yourgene Health (LON:YGEN) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Abingdon Health has higher earnings, but lower revenue than Yourgene Health. Abingdon Health is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£10.99M3.17-£796.37K-£0.51N/A
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A

In the previous week, Abingdon Health had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for Yourgene Health. Abingdon Health's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
Yourgene Health Neutral

0.8% of Abingdon Health shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 5.4% of Abingdon Health shares are held by insiders. Comparatively, 64.4% of Yourgene Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Abingdon Health has a net margin of -19.36% compared to Yourgene Health's net margin of -27.55%. Yourgene Health's return on equity of -27.06% beat Abingdon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-19.36% -34.31% -17.93%
Yourgene Health -27.55%-27.06%-6.71%

Abingdon Health has a beta of 0.132, suggesting that its share price is 87% less volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Summary

Yourgene Health beats Abingdon Health on 7 of the 11 factors compared between the two stocks.

How does Abingdon Health compare to genedrive?

Abingdon Health (LON:ABDX) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£10.99M3.17-£796.37K-£0.51N/A
genedrive£929K15.47-£21.22M-£0.79N/A

Abingdon Health has a net margin of -19.36% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -34.31% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-19.36% -34.31% -17.93%
genedrive -500.75%-1,044.57%-74.09%

Abingdon Health has a beta of 0.132, meaning that its share price is 87% less volatile than the broader market. Comparatively, genedrive has a beta of 1.004, meaning that its share price is 0% more volatile than the broader market.

In the previous week, Abingdon Health and Abingdon Health both had 1 articles in the media. genedrive's average media sentiment score of 0.67 beat Abingdon Health's score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abingdon Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
genedrive
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

0.8% of Abingdon Health shares are owned by institutional investors. Comparatively, 0.1% of genedrive shares are owned by institutional investors. 5.4% of Abingdon Health shares are owned by insiders. Comparatively, 28.1% of genedrive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Abingdon Health beats genedrive on 7 of the 12 factors compared between the two stocks.

How does Abingdon Health compare to Verici Dx?

Abingdon Health (LON:ABDX) and Verici Dx (LON:VRCI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

0.8% of Abingdon Health shares are owned by institutional investors. Comparatively, 9.9% of Verici Dx shares are owned by institutional investors. 5.4% of Abingdon Health shares are owned by company insiders. Comparatively, 1.1% of Verici Dx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Abingdon Health has a beta of 0.132, suggesting that its share price is 87% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.222, suggesting that its share price is 22% more volatile than the broader market.

Abingdon Health has a net margin of -19.36% compared to Verici Dx's net margin of -223.60%. Abingdon Health's return on equity of -34.31% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-19.36% -34.31% -17.93%
Verici Dx -223.60%-127.57%-26.14%

Abingdon Health has higher revenue and earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£10.99M3.17-£796.37K-£0.51N/A
Verici Dx£3.52M3.59-£6.56M£0.101.90

In the previous week, Abingdon Health had 1 more articles in the media than Verici Dx. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for Verici Dx. Abingdon Health's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
Verici Dx Neutral

Summary

Abingdon Health beats Verici Dx on 7 of the 12 factors compared between the two stocks.

How does Abingdon Health compare to ANGLE?

Abingdon Health (LON:ABDX) and ANGLE (LON:AGL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Abingdon Health has a net margin of -19.36% compared to ANGLE's net margin of -1,560.86%. Abingdon Health's return on equity of -34.31% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-19.36% -34.31% -17.93%
ANGLE -1,560.86%-157.49%-29.89%

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£10.99M3.17-£796.37K-£0.51N/A
ANGLE£2.62M2.89-£21.76M-£4.80N/A

0.8% of Abingdon Health shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 5.4% of Abingdon Health shares are owned by company insiders. Comparatively, 2.7% of ANGLE shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Abingdon Health has a beta of 0.132, indicating that its stock price is 87% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

In the previous week, Abingdon Health had 1 more articles in the media than ANGLE. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for ANGLE. Abingdon Health's average media sentiment score of 0.00 equaled ANGLE'saverage media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
ANGLE Neutral

Summary

Abingdon Health beats ANGLE on 9 of the 12 factors compared between the two stocks.

How does Abingdon Health compare to Proteome Sciences?

Abingdon Health (LON:ABDX) and Proteome Sciences (LON:PRM) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Abingdon Health has a net margin of -19.36% compared to Proteome Sciences' net margin of -61.46%. Proteome Sciences' return on equity of 23.85% beat Abingdon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-19.36% -34.31% -17.93%
Proteome Sciences -61.46%23.85%-19.25%

Abingdon Health has higher revenue and earnings than Proteome Sciences. Abingdon Health is trading at a lower price-to-earnings ratio than Proteome Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£10.99M3.17-£796.37K-£0.51N/A
Proteome Sciences£3.77M1.28-£4.08M-£0.72N/A

Abingdon Health has a beta of 0.132, meaning that its stock price is 87% less volatile than the broader market. Comparatively, Proteome Sciences has a beta of 0.157, meaning that its stock price is 84% less volatile than the broader market.

In the previous week, Abingdon Health had 1 more articles in the media than Proteome Sciences. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for Proteome Sciences. Abingdon Health's average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
Proteome Sciences Neutral

0.8% of Abingdon Health shares are held by institutional investors. Comparatively, 0.0% of Proteome Sciences shares are held by institutional investors. 5.4% of Abingdon Health shares are held by insiders. Comparatively, 36.7% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Abingdon Health beats Proteome Sciences on 8 of the 12 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

ABDX vs. The Competition

MetricAbingdon HealthLife Sciences Tools & Services IndustryHealthcare SectorLON Exchange
Market Cap£34.81M£10.76B£7.72B£2.74B
Dividend YieldN/A1.46%2.47%5.11%
P/E Ratio-15.6951.2132.9523.17
Price / Sales3.177.448.215.06
Price / Cash2.2526.3620.8520.23
Price / Book10.994.414.432.46
Net Income-£796.37K£57.47B£3.51B£5.88B
7 Day PerformanceN/A-2.11%-4.73%-1.74%
1 Month Performance-9.96%-1.51%-5.69%-3.52%
1 Year Performance14.29%19.66%-1.18%6.90%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 8
-5.9%
N/A+20.1%£34.81M£10.99MN/A84
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67MN/A253
GDR
genedrive
N/AGBX 0.89
-1.3%
N/A-7.7%£14.26M£929KN/A43
VRCI
Verici Dx
N/AGBX 0.20
-1.0%
N/A-74.0%£13.52M£3.52M2.0319
AGL
ANGLE
N/AGBX 2.35
-11.3%
N/A+0.0%£7.58M£2.62MN/A650

Related Companies and Tools


This page (LON:ABDX) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners